Clinical Trial Update: GARDASIL™ Post Marketing Surveillance in the Philippines (V501-077)

View source ↗

Summary

Gardasil post-marketing surveillance in the Philippines has been terminated. The study was sponsored by Merck Sharp & Dohme LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• Gardasil (human papillomavirus vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Papillomavirus Infections | Status: TERMINATED